Related references
Note: Only part of the references are listed.Interleukin 6 (IL-6) Deficiency Delays Lupus Nephritis in MRL-Fas(lpr) Mice: The IL-6 Pathway as a New Therapeutic Target in Treatment of Autoimmune Kidney Disease in Systemic Lupus Erythematosus
Hannes Cash et al.
JOURNAL OF RHEUMATOLOGY (2010)
Interleukin-6 aborts lymphopoiesis and elevates production of myeloid cells in systemic lupus erythematosus-prone B6.Sle1.Yaa animals
Kenichiro Maeda et al.
BLOOD (2009)
Interleukin-17 and systemic lupus erythematosus: current concepts
A. Nalbandian et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
IL-17 producing CD4+ T cells mediate accelerated ischemia/reperfusion-induced injury in autoimmunity-prone mice
Colin Edgerton et al.
CLINICAL IMMUNOLOGY (2009)
Accuracy of cerebrospinal fluid IL-6 testing for diagnosis of lupus psychosis. A multicenter retrospective study
Shunsei Hirohata et al.
CLINICAL RHEUMATOLOGY (2009)
Innate immunity to virus infection
Osamu Takeuchi et al.
IMMUNOLOGICAL REVIEWS (2009)
Potent Induction of IFN-α and Chemokines by Autoantibodies in the Cerebrospinal Fluid of Patients with Neuropsychiatric Lupus
Deanna M. Santer et al.
JOURNAL OF IMMUNOLOGY (2009)
IL-6 Modulates CD5 Expression in B Cells from Patients with Lupus by Regulating DNA Methylation
Soizic Garaud et al.
JOURNAL OF IMMUNOLOGY (2009)
The Role of IL-23/IL-17 Axis in Lupus Nephritis
Zheng Zhang et al.
JOURNAL OF IMMUNOLOGY (2009)
Raised expression of cytokine receptor gp130 subunit on peripheral lymphocytes of patients with active lupus. A useful tool for monitoring the disease activity?
M. De La Torre et al.
LUPUS (2009)
Interleukin-6 release from peripheral mononuclear cells is associated to disease activity and treatment response in patients with lupus nephritis
Pasquale Esposito et al.
LUPUS (2009)
Epidermal loss of JunB leads to a SLE phenotype due to hyper IL-6 signaling
Pamina Pflegerl et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Age- and sex-related patterns of serum interferon-α activity in lupus families
Timothy B. Niewold et al.
ARTHRITIS AND RHEUMATISM (2008)
Association of the IRF5 risk haplotype with high serum interferon-α activity in systemic lupus erythematosus patients
Timothy B. Niewold et al.
ARTHRITIS AND RHEUMATISM (2008)
Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: Implications for Th17-mediated inflammation in auto-immunity
Chun Kwok Wong et al.
CLINICAL IMMUNOLOGY (2008)
Plasmacytoid dendritic cells and type I IFN: 50 years of convergent history
Patricia Fitzgerald-Bocarsly et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
Systemic IFN-α drives kidney nephritis in B6.Sle123 mice
Anna-Marie Fairhurst et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5
Snaevar Sigurdsson et al.
HUMAN MOLECULAR GENETICS (2008)
Autoreactive B Cells Discriminate CpG-Rich and CpG-Poor DNA and This Response Is Modulated by IFN-α
Melissa B. Uccellini et al.
JOURNAL OF IMMUNOLOGY (2008)
Expanded Double Negative T Cells in Patients with Systemic Lupus Erythematosus Produce IL-17 and Infiltrate the Kidneys
Jose C. Crispin et al.
JOURNAL OF IMMUNOLOGY (2008)
Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus
Richard Furie et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Association of elevated transcript levels of interferon-inducible chemokines with disease activity and organ damage in systemic lupus erythematosus patients
Qiong Fu et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Interferon-α induces up-regulation and nuclear translocation of the Ro52 autoantigen as detected by a panel of novel Ro52-specific monoclonal antibodies
Linn Strandberg et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2008)
TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts
Claudia Bossen et al.
BLOOD (2008)
Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice
Hui-Chen Hsu et al.
NATURE IMMUNOLOGY (2008)
Glomerular accumulation of plasmacytoid dendritic cells in active lupus nephritis
Marco Tucci et al.
ARTHRITIS AND RHEUMATISM (2008)
Reduced B lymphocyte and immunoglobulin levels after atacicept treatment in patients with systemic lupus erythematosus
Maria Dall'Era et al.
ARTHRITIS AND RHEUMATISM (2007)
STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus
Elaine F. Remmers et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
High serum IFN-α activity is a heritable risk factor for systemic lupus erythematosus
T. B. Niewold et al.
GENES AND IMMUNITY (2007)
Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells
Hee-Kap Kang et al.
JOURNAL OF IMMUNOLOGY (2007)
Safety and efficacy of infliximab in a patient with active WHO class IV lupus nephritis
Sawsan J. Hayat et al.
CLINICAL RHEUMATOLOGY (2007)
Association of polymorphisms across the tyrosine kinase gene, TYK2 in UKSLE families
D. S. C. Graham et al.
RHEUMATOLOGY (2007)
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
Roberto Baccala et al.
NATURE MEDICINE (2007)
The role of BLyS/BLyS receptors in anti-chromatin B cell regulation
Brian D. Hondowicz et al.
INTERNATIONAL IMMUNOLOGY (2007)
Elevated serum levels of interferon-regulated chemokines are biomarkers for active human systemic lupus erythematosus
Jason W. Bauer et al.
PLOS MEDICINE (2006)
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
E Bettelli et al.
NATURE (2006)
Transforming growth factor-β induces development of the TH17 lineage
PR Mangan et al.
NATURE (2006)
Cutting edge: Enhancement of antibody responses through direct stimulation of B and T cells by type IIFN
A Le Bon et al.
JOURNAL OF IMMUNOLOGY (2006)
The Toll-like receptors: analysis by forward genetic methods
B Beutler
IMMUNOGENETICS (2005)
Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus
S Sigurdsson et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
CL Langrish et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Effect of neutralizing antibodies to IL-10 and C5 on the renal damage caused by a pathogenic human anti-dsDNA antibody
CT Ravirajan et al.
RHEUMATOLOGY (2004)
Safety and efficacy of tumor necrosis factor α blockade in systemic lupus erythematosus -: An open-label study
M Aringer et al.
ARTHRITIS AND RHEUMATISM (2004)
Induction of interferon-a production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late anoptotic cells and lupus IgG
T Lövgren et al.
ARTHRITIS AND RHEUMATISM (2004)
Rationale for interleukin-6 blockade in systemic lupus erythematosus
E Tackey et al.
LUPUS (2004)
Coupling between B cell receptor and phospholipase C-γ2 is essential for mature B cell development
M Hikida et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Cytokine balance in kidney tissue from lupus nephritis patients
WS Uhm et al.
RHEUMATOLOGY (2003)
NF-κB1 p50 is required for BLyS attenuation of apoptosis but dispensable for processing of NF-κB2 p100 to p52 in quiescent mature B cells
EN Hatada et al.
JOURNAL OF IMMUNOLOGY (2003)
Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice
ML Santiago-Raber et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
EC Baechler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17
S Aggarwal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an Fc gamma RII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE
J Ronnelid et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus - Longitudinal observations
W Stohl et al.
ARTHRITIS AND RHEUMATISM (2003)
Drug-induced systemic lupus erythematosus and TNF-α blockers
AK Mohan et al.
LANCET (2002)
Drug-induced systemic lupus erythematosus associated with etanercept therapy
N Shakoor et al.
LANCET (2002)
Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency
MH Yan et al.
CURRENT BIOLOGY (2001)
An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway
B Schiemann et al.
SCIENCE (2001)
B-cell maturation protein, which binds the tumor necrosis factor family members BAFF and APRIL, is dispensable for humoral immune responses
SL Xu et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus
S Blomberg et al.
LUPUS (2001)
Synthesis and release of B-lymphocyte stimulator from myeloid cells
B Nardelli et al.
BLOOD (2001)
BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population
JS Thompson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Increased excretions of β2-microglobulin, IL-6, and IL-8 and decreased excretion of Tamm-Horsfall glycoprotein in urine of patients with active lupus nephritis
CY Tsai et al.
NEPHRON (2000)
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
JA Gross et al.
NATURE (2000)
Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies
AA Bengtsson et al.
LUPUS (2000)
Share Paper
